+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

Myelofibrosis Epidemiology Analysis and Forecast, 2021-2031 - Product Thumbnail Image

Myelofibrosis Epidemiology Analysis and Forecast, 2021-2031

  • Report
  • July 2022
  • 56 Pages
  • Global
From
Nasopharyngeal Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Nasopharyngeal Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • July 2022
  • 521 Pages
  • Global
From
Immuno-Oncology - Thematic Research - Product Thumbnail Image

Immuno-Oncology - Thematic Research

  • Report
  • May 2022
  • 167 Pages
  • Global
From
Neuroendocrine Tumors Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Neuroendocrine Tumors Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • May 2022
  • 76 Pages
  • Global
From
Cervical Cancer Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2020-2030 - Product Thumbnail Image

Cervical Cancer Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2020-2030

  • Drug Pipelines
  • February 2022
  • 150 Pages
  • Global
From
Cervical Cancer - Epidemiology Forecast to 2030 - Product Thumbnail Image

Cervical Cancer - Epidemiology Forecast to 2030

  • Report
  • January 2022
  • 41 Pages
  • Global
From
Brain Cancer - Epidemiology Forecast to 2030 - Product Thumbnail Image

Brain Cancer - Epidemiology Forecast to 2030

  • Report
  • December 2021
  • 42 Pages
  • Global
From
Glioblastoma Multiforme - Global Drug Forecast and Market Analysis to 2030 - Product Thumbnail Image

Glioblastoma Multiforme - Global Drug Forecast and Market Analysis to 2030

  • Report
  • December 2021
  • 127 Pages
  • Global
From
Endometrial Cancer - Global Drug Forecast and Market Analysis to 2030 - Product Thumbnail Image

Endometrial Cancer - Global Drug Forecast and Market Analysis to 2030

  • Report
  • May 2021
  • Global
From
Endometrial Cancer - Epidemiology Forecast to 2030 - Product Thumbnail Image

Endometrial Cancer - Epidemiology Forecast to 2030

  • Report
  • May 2021
  • 42 Pages
  • Global
From
Hepatocellular Carcinoma - Opportunity Analysis and Forecasts to 2029 - Product Thumbnail Image

Hepatocellular Carcinoma - Opportunity Analysis and Forecasts to 2029

  • Report
  • March 2021
  • 214 Pages
  • Global
From
Acute Myeloid Leukemia - Epidemiology Forecast to 2029 - Product Thumbnail Image

Acute Myeloid Leukemia - Epidemiology Forecast to 2029

  • Report
  • June 2020
  • 37 Pages
  • Global
From
Renal Cell Carcinoma: Global Drug Forecast and Market Analysis to 2028 - Product Thumbnail Image

Renal Cell Carcinoma: Global Drug Forecast and Market Analysis to 2028

  • Report
  • February 2020
  • 160 Pages
  • Global
From
Prostate Cancer: Global Drug Forecast and Market Analysis to 2028 - Product Thumbnail Image

Prostate Cancer: Global Drug Forecast and Market Analysis to 2028

  • Report
  • August 2019
  • 212 Pages
  • Global
From
Ovarian Cancer: Epidemiology Forecast to 2028 - Product Thumbnail Image

Ovarian Cancer: Epidemiology Forecast to 2028

  • Report
  • July 2019
  • 46 Pages
  • Global
From
Multiple Myeloma: Global Drug Forecast and Market Analysis to 2027 - Product Thumbnail Image

Multiple Myeloma: Global Drug Forecast and Market Analysis to 2027

  • Report
  • March 2019
  • 164 Pages
  • Global
From
Multiple Myeloma: Epidemiology Forecast to 2027 - Product Thumbnail Image

Multiple Myeloma: Epidemiology Forecast to 2027

  • Report
  • March 2019
  • 42 Pages
  • Global
From
Chronic Lymphocytic Leukemia: Epidemiology Forecast to 2027 - Product Thumbnail Image

Chronic Lymphocytic Leukemia: Epidemiology Forecast to 2027

  • Report
  • November 2018
  • 43 Pages
  • Global
From
Market Access, Pricing and Reimbursement of Oncology Medicines in the 5EU - Product Thumbnail Image

Market Access, Pricing and Reimbursement of Oncology Medicines in the 5EU

  • Report
  • September 2018
  • 162 Pages
  • Global
From
Silent Cancer Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Silent Cancer Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • July 2024
  • 91 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more